Cell and Gene Therapy  Cell and Gene Therapy University College London ../webroot/files/Institutions/cover_photo/1563944035University-London-1.jpg

This Master s degree in Cell and Gene Therapy provides an in-depth education in this cutting edge and rapidly developing field. It is delivered by scientists and clinicians researching, developing and testing new treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation and DNA repair techniques. What and how will I learn? The degree covers all aspects of the subject, including basic biomedical science, molecular basis of disease, current and developing technologies and clinical applications. Students also receive vocational training in research methodology and statistics, how to perform a research project and in completing a practical laboratory based project. Degree Structure Students undertake courses to the value of 180 credits. The MSc programme consists of four core courses (60 credits), four optional courses (60 credits) and a research dissertation (60 credits). A Postgraduate Diploma (120 credits, full-time nine months or part-time up to five years) is offered A Postgraduate Certificate (60 credits, full-time 12 weeks or up to two years part-time) is offered. Core modules Foundations of Biomedical Sciences Molecular Aspects of Cell and Gene Therapy Clinical Applications of Cell and Gene Therapy Research Methodology and Statistics Options Investigating Research Applied Genomics Stem Cell and Tissue Repair HIV Frontiers from Research to Clinics Disease to Gene to Therapy Molecular and Genetic Basis of Paediatric Disease Dissertationreport All MSc students undertake an independent research project which culminates in a dissertation. Teaching includes lectures, seminars, problem classes and tutorials. Course assessment varies depending on the course, but includes written coursework, multiple-choice questions, written examinations, a practical analysis exam and the dissertation. Further details available on subject website: http:www.ucl.ac.ukcell-gene-therapy Why should I study this degree at UCL? The Institute of Child Health (ICH), and its clinical partner Great Ormond Street Hospital (GOSH), is the largest centre in Europe devoted to clinical and basic research and post-graduate education in children s health. ICHGOSH is a major centre for cell therapy, including haematopoietic stem cell transplantation (HSCT) and gene therapy. This centre has treated more patients in clinical trials of gene therapy than any other institution worldwide, currently conducting three clinical trials of gene therapy for three separate disorders, with clinical trials for additional disorders, including some forms of cancer, in development. There is a strong research interest in cell and gene therapy within the Faculty of Biomedical Sciences at UCL, which has the largest concentration of clinicians and researchers active in this area of translational medicine in Europe. This is reflected by many groups conducting high-quality research and clinical trials using gene or cell therapy, including Infection and Immunity, Institute of Ophthalmology, Institute for Women s Health, Institute of Genetics and the Cancer Institute. Your career The first cohort of students admitted to the Cell and Gene Therapy MSc programme are due to graduate in 2012. Therefore, no information about career destinations for students on this programme is currently available. Entry requirements Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MB BS, a non-clinical scientist with a minimum of a lower second-class BSc or equivalent in a life or biomedical science subjector a healthcare, pharmaceutical or biotech professional and scientist with equivalent experience (minimum 3 years). How to apply You may choose to apply online or download application materials, for details visit http:www.ucl.ac.ukprospective-studentsgraduate-studyapplication-admission Students are advised to apply as early as possible. Those applying for scholarship funding (particularly overseas app

Applicants should be: a qualified medical practitioner, with a qualification equivalent to a UK MB BS, a non-clinical scientist with a minimum of an upper second-class BSc or equivalent in a life or biomedical science subject; or a healthcare, pharmaceuti fundingItemalue+oSn++???A??